COVID-19 pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 12: Line 12:
* Coronavirus disease 2019 (COVID-19) is caused by, SARS-CoV-2, a novel coronavirus named for the similarity of its symptoms to those caused by the severe acute respiratory syndrome.<ref name="LuCui2020">{{cite journal|last1=Lu|first1=Jian|last2=Cui|first2=Jie|last3=Qian|first3=Zhaohui|last4=Wang|first4=Yirong|last5=Zhang|first5=Hong|last6=Duan|first6=Yuange|last7=Wu|first7=Xinkai|last8=Yao|first8=Xinmin|last9=Song|first9=Yuhe|last10=Li|first10=Xiang|last11=Wu|first11=Changcheng|last12=Tang|first12=Xiaolu|title=On the origin and continuing evolution of SARS-CoV-2|journal=National Science Review|year=2020|issn=2095-5138|doi=10.1093/nsr/nwaa036}}</ref><ref name="LuZhao2020">{{cite journal|last1=Lu|first1=Roujian|last2=Zhao|first2=Xiang|last3=Li|first3=Juan|last4=Niu|first4=Peihua|last5=Yang|first5=Bo|last6=Wu|first6=Honglong|last7=Wang|first7=Wenling|last8=Song|first8=Hao|last9=Huang|first9=Baoying|last10=Zhu|first10=Na|last11=Bi|first11=Yuhai|last12=Ma|first12=Xuejun|last13=Zhan|first13=Faxian|last14=Wang|first14=Liang|last15=Hu|first15=Tao|last16=Zhou|first16=Hong|last17=Hu|first17=Zhenhong|last18=Zhou|first18=Weimin|last19=Zhao|first19=Li|last20=Chen|first20=Jing|last21=Meng|first21=Yao|last22=Wang|first22=Ji|last23=Lin|first23=Yang|last24=Yuan|first24=Jianying|last25=Xie|first25=Zhihao|last26=Ma|first26=Jinmin|last27=Liu|first27=William J|last28=Wang|first28=Dayan|last29=Xu|first29=Wenbo|last30=Holmes|first30=Edward C|last31=Gao|first31=George F|last32=Wu|first32=Guizhen|last33=Chen|first33=Weijun|last34=Shi|first34=Weifeng|last35=Tan|first35=Wenjie|title=Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding|journal=The Lancet|volume=395|issue=10224|year=2020|pages=565–574|issn=01406736|doi=10.1016/S0140-6736(20)30251-8}}</ref>
* Coronavirus disease 2019 (COVID-19) is caused by, SARS-CoV-2, a novel coronavirus named for the similarity of its symptoms to those caused by the severe acute respiratory syndrome.<ref name="LuCui2020">{{cite journal|last1=Lu|first1=Jian|last2=Cui|first2=Jie|last3=Qian|first3=Zhaohui|last4=Wang|first4=Yirong|last5=Zhang|first5=Hong|last6=Duan|first6=Yuange|last7=Wu|first7=Xinkai|last8=Yao|first8=Xinmin|last9=Song|first9=Yuhe|last10=Li|first10=Xiang|last11=Wu|first11=Changcheng|last12=Tang|first12=Xiaolu|title=On the origin and continuing evolution of SARS-CoV-2|journal=National Science Review|year=2020|issn=2095-5138|doi=10.1093/nsr/nwaa036}}</ref><ref name="LuZhao2020">{{cite journal|last1=Lu|first1=Roujian|last2=Zhao|first2=Xiang|last3=Li|first3=Juan|last4=Niu|first4=Peihua|last5=Yang|first5=Bo|last6=Wu|first6=Honglong|last7=Wang|first7=Wenling|last8=Song|first8=Hao|last9=Huang|first9=Baoying|last10=Zhu|first10=Na|last11=Bi|first11=Yuhai|last12=Ma|first12=Xuejun|last13=Zhan|first13=Faxian|last14=Wang|first14=Liang|last15=Hu|first15=Tao|last16=Zhou|first16=Hong|last17=Hu|first17=Zhenhong|last18=Zhou|first18=Weimin|last19=Zhao|first19=Li|last20=Chen|first20=Jing|last21=Meng|first21=Yao|last22=Wang|first22=Ji|last23=Lin|first23=Yang|last24=Yuan|first24=Jianying|last25=Xie|first25=Zhihao|last26=Ma|first26=Jinmin|last27=Liu|first27=William J|last28=Wang|first28=Dayan|last29=Xu|first29=Wenbo|last30=Holmes|first30=Edward C|last31=Gao|first31=George F|last32=Wu|first32=Guizhen|last33=Chen|first33=Weijun|last34=Shi|first34=Weifeng|last35=Tan|first35=Wenjie|title=Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding|journal=The Lancet|volume=395|issue=10224|year=2020|pages=565–574|issn=01406736|doi=10.1016/S0140-6736(20)30251-8}}</ref>
*Unlike SARS-CoV, transmission of COVID-19 takes place during the prodromal period when those infected are mildly ill and are carrying on with their usual activities. This contributes to the spread of infection.<ref name="HeymannShindo2020">{{cite journal|last1=Heymann|first1=David L|last2=Shindo|first2=Nahoko|title=COVID-19: what is next for public health?|journal=The Lancet|volume=395|issue=10224|year=2020|pages=542–545|issn=01406736|doi=10.1016/S0140-6736(20)30374-3}}</ref>
*Unlike SARS-CoV, transmission of COVID-19 takes place during the prodromal period when those infected are mildly ill and are carrying on with their usual activities. This contributes to the spread of infection.<ref name="HeymannShindo2020">{{cite journal|last1=Heymann|first1=David L|last2=Shindo|first2=Nahoko|title=COVID-19: what is next for public health?|journal=The Lancet|volume=395|issue=10224|year=2020|pages=542–545|issn=01406736|doi=10.1016/S0140-6736(20)30374-3}}</ref>
*The main pathogenesis of COVID-19 is severe pneumonia, RNAemia, combined with the incidence of ground-glass opacities, and acute cardiac injury.<ref name="HuangWang2020">{{cite journal|last1=Huang|first1=Chaolin|last2=Wang|first2=Yeming|last3=Li|first3=Xingwang|last4=Ren|first4=Lili|last5=Zhao|first5=Jianping|last6=Hu|first6=Yi|last7=Zhang|first7=Li|last8=Fan|first8=Guohui|last9=Xu|first9=Jiuyang|last10=Gu|first10=Xiaoying|last11=Cheng|first11=Zhenshun|last12=Yu|first12=Ting|last13=Xia|first13=Jiaan|last14=Wei|first14=Yuan|last15=Wu|first15=Wenjuan|last16=Xie|first16=Xuelei|last17=Yin|first17=Wen|last18=Li|first18=Hui|last19=Liu|first19=Min|last20=Xiao|first20=Yan|last21=Gao|first21=Hong|last22=Guo|first22=Li|last23=Xie|first23=Jungang|last24=Wang|first24=Guangfa|last25=Jiang|first25=Rongmeng|last26=Gao|first26=Zhancheng|last27=Jin|first27=Qi|last28=Wang|first28=Jianwei|last29=Cao|first29=Bin|title=Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China|journal=The Lancet|volume=395|issue=10223|year=2020|pages=497–506|issn=01406736|doi=10.1016/S0140-6736(20)30183-5}}</ref><br />
*The main pathogenesis of COVID-19 is severe pneumonia, RNAemia, combined with the incidence of ground-glass opacities, and acute cardiac injury.<ref name="HuangWang2020">{{cite journal|last1=Huang|first1=Chaolin|last2=Wang|first2=Yeming|last3=Li|first3=Xingwang|last4=Ren|first4=Lili|last5=Zhao|first5=Jianping|last6=Hu|first6=Yi|last7=Zhang|first7=Li|last8=Fan|first8=Guohui|last9=Xu|first9=Jiuyang|last10=Gu|first10=Xiaoying|last11=Cheng|first11=Zhenshun|last12=Yu|first12=Ting|last13=Xia|first13=Jiaan|last14=Wei|first14=Yuan|last15=Wu|first15=Wenjuan|last16=Xie|first16=Xuelei|last17=Yin|first17=Wen|last18=Li|first18=Hui|last19=Liu|first19=Min|last20=Xiao|first20=Yan|last21=Gao|first21=Hong|last22=Guo|first22=Li|last23=Xie|first23=Jungang|last24=Wang|first24=Guangfa|last25=Jiang|first25=Rongmeng|last26=Gao|first26=Zhancheng|last27=Jin|first27=Qi|last28=Wang|first28=Jianwei|last29=Cao|first29=Bin|title=Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China|journal=The Lancet|volume=395|issue=10223|year=2020|pages=497–506|issn=01406736|doi=10.1016/S0140-6736(20)30183-5}}</ref>
*Initial reports identified two species of snakes that could be the culprit reservoir of COVID-19. However, there is no consistent evidence of coronavirus reservoirs except mammals and birds.<ref name="BassettiVena2020">{{cite journal|last1=Bassetti|first1=Matteo|last2=Vena|first2=Antonio|last3=Giacobbe|first3=Daniele Roberto|title=The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm|journal=European Journal of Clinical Investigation|volume=50|issue=3|year=2020|issn=0014-2972|doi=10.1111/eci.13209}}</ref><br />
==Reference==
==Reference==
{{reflist|2}}
{{reflist|2}}

Revision as of 20:56, 9 March 2020

COVID-19 Microchapters

Home

Long COVID

Frequently Asked Outpatient Questions

Frequently Asked Inpatient Questions

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating COVID-19 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Vaccines

Secondary Prevention

Future or Investigational Therapies

Ongoing Clinical Trials

Case Studies

Case #1

COVID-19 pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of COVID-19 pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on COVID-19 pathophysiology

CDC on COVID-19 pathophysiology

COVID-19 pathophysiology in the news

Blogs on COVID-19 pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for COVID-19 pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Coronavirus disease 2019 (COVID-19) is caused by, SARS-CoV-2, a novel coronavirus named for the similarity of its symptoms to those caused by the severe acute respiratory syndrome.

Pathophysiology

Pathogenesis

  • Coronavirus disease 2019 (COVID-19) is caused by, SARS-CoV-2, a novel coronavirus named for the similarity of its symptoms to those caused by the severe acute respiratory syndrome.[1][2]
  • Unlike SARS-CoV, transmission of COVID-19 takes place during the prodromal period when those infected are mildly ill and are carrying on with their usual activities. This contributes to the spread of infection.[3]
  • The main pathogenesis of COVID-19 is severe pneumonia, RNAemia, combined with the incidence of ground-glass opacities, and acute cardiac injury.[4]
  • Initial reports identified two species of snakes that could be the culprit reservoir of COVID-19. However, there is no consistent evidence of coronavirus reservoirs except mammals and birds.[5]

Reference

  1. Lu, Jian; Cui, Jie; Qian, Zhaohui; Wang, Yirong; Zhang, Hong; Duan, Yuange; Wu, Xinkai; Yao, Xinmin; Song, Yuhe; Li, Xiang; Wu, Changcheng; Tang, Xiaolu (2020). "On the origin and continuing evolution of SARS-CoV-2". National Science Review. doi:10.1093/nsr/nwaa036. ISSN 2095-5138.
  2. Lu, Roujian; Zhao, Xiang; Li, Juan; Niu, Peihua; Yang, Bo; Wu, Honglong; Wang, Wenling; Song, Hao; Huang, Baoying; Zhu, Na; Bi, Yuhai; Ma, Xuejun; Zhan, Faxian; Wang, Liang; Hu, Tao; Zhou, Hong; Hu, Zhenhong; Zhou, Weimin; Zhao, Li; Chen, Jing; Meng, Yao; Wang, Ji; Lin, Yang; Yuan, Jianying; Xie, Zhihao; Ma, Jinmin; Liu, William J; Wang, Dayan; Xu, Wenbo; Holmes, Edward C; Gao, George F; Wu, Guizhen; Chen, Weijun; Shi, Weifeng; Tan, Wenjie (2020). "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding". The Lancet. 395 (10224): 565–574. doi:10.1016/S0140-6736(20)30251-8. ISSN 0140-6736.
  3. Heymann, David L; Shindo, Nahoko (2020). "COVID-19: what is next for public health?". The Lancet. 395 (10224): 542–545. doi:10.1016/S0140-6736(20)30374-3. ISSN 0140-6736.
  4. Huang, Chaolin; Wang, Yeming; Li, Xingwang; Ren, Lili; Zhao, Jianping; Hu, Yi; Zhang, Li; Fan, Guohui; Xu, Jiuyang; Gu, Xiaoying; Cheng, Zhenshun; Yu, Ting; Xia, Jiaan; Wei, Yuan; Wu, Wenjuan; Xie, Xuelei; Yin, Wen; Li, Hui; Liu, Min; Xiao, Yan; Gao, Hong; Guo, Li; Xie, Jungang; Wang, Guangfa; Jiang, Rongmeng; Gao, Zhancheng; Jin, Qi; Wang, Jianwei; Cao, Bin (2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". The Lancet. 395 (10223): 497–506. doi:10.1016/S0140-6736(20)30183-5. ISSN 0140-6736.
  5. Bassetti, Matteo; Vena, Antonio; Giacobbe, Daniele Roberto (2020). "The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm". European Journal of Clinical Investigation. 50 (3). doi:10.1111/eci.13209. ISSN 0014-2972.